Filing Details
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2009-11-13 11:30:40
- Reporting Period:
- 2009-11-12
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1006281 | Protalix Biotherapeutics Inc. | PLX | () |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1385120 | Eli Hurvitz | C/O Protalix Biotherapeutics, Inc. 2 Snunit Street Science Park, Pob 455 Carmiel L3 20100 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2009-11-12 | 250,000 | $10.76 | 1,514,480 | No | 4 | S | Indirect | by Partnership |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | by Partnership |
Billionaire Hedge Funds
